Antares Pharma Inc. (ATRS)

3.42
0.01 0.29
NASDAQ : Health Technology
Prev Close 3.43
Open 3.41
Day Low/High 3.39 / 3.44
52 Wk Low/High 2.53 / 3.96
Volume 38.95K
Avg Volume 810.80K
Exchange NASDAQ
Shares Outstanding 163.06M
Market Cap 564.19M
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Stocks Under $10 Weekly Summary

We shed our remaining shares of Sutter Rock Capital last week as the Russell 2000 declined.

Stocks Under $10 Weekly Summary

It was a challenging week for the portfolio, as it was for the markets in general, as only of our active positions finished the week higher.

Stocks Under $10 Weekly Summary

Last week we started a small position in Digital Turbine and added to two other holdings.

Stocks Under $10 Weekly Summary

We exited one position and initiated a new one as eight of our holdings outpaced the Russell 2000's 5% increase last week.

Stocks Under $10 Weekly Summary

We made several trades last week, as all the major stock market indices posted gains.

Stocks Under $10 Weekly Summary

We saw some meaningful swings, both positive and negative, in several portfolio positions last week.

Stocks Under $10 Weekly Summary

We trimmed our holdings in 2 positions and added to another last week as the Russell 2000 took a hit.

Hear Now the News (and Updates) on 2 Key Positions

Antares Pharma and Encana are on our radar today.

Stocks Under $10 Weekly Summary

We made several trades last week as all the major domestic stock market indices moved lower for the five days.

Stocks Under $10 Weekly Summary

Our portfolio fell along with the broader market (especially small-caps), but there were some bright spots as well.

Earnings Buffet: Updates on 4 Portfolio Names

Here's our current thinking on AcelRx Pharmaceuticals, Antares Pharma, CPI Aerostructures and Pareteum.

Antares Pharma Reports Second Quarter 2019 Operating And Financial Results

Antares Pharma Reports Second Quarter 2019 Operating And Financial Results

Record Quarterly Revenue of $28.4 Million - Double Second Quarter 2018 Revenue The Company Increases Full Year 2019 Revenue Guidance to a Range of $100.

Stocks Under $10 Weekly Summary

While the portfolio experienced some pain last week along with the broader market, 12 of our holdings beat the Russell 2000 either on an absolute or relative basis.

Stocks Under $10 Weekly Summary

We exited a position last week for a nice gain as the market continued to rise.

Stocks Under $10 Weekly Summary

As the momentum of earnings season rose last week, we made several trades including initiating a new position in Innovative Solutions and Support.

Stocks Under $10 Weekly Summary

We added to one position last week as as the small-cap heavy Russell 2000 dipped.

Stocks Under $10 Weekly Summary

We added to one position and initiated another during a shortened holiday week.

Stocks Under $10 Weekly Summary

We initiated a new position and added to a couple of others as we closed the books on the second quarter.

Interesting ATRS Put And Call Options For February 2020

Interesting ATRS Put And Call Options For February 2020

Investors in Antares Pharma Inc. saw new options begin trading this week, for the February 2020 expiration.

Stocks Under $10 Weekly Summary

Last week we started two new positions, trimmed a winner and exited another name as the markets moved higher across the board.

Stocks Under $10 Weekly Summary

With the market rising last week, we saw favorable action in several of our holdings and booked some hefty gains in one name.

Stocks Under $10 Weekly Summary

With the market rebounding, the majority of our positions rose week over week.

Stocks Under $10 Weekly Summary

During the week, we exited our position in KushCo Holdings and initiated Antares Pharma.

An Initiation and an Exit

We will close out KushCo Holdings, largely replacing it with an initial position in Antares Pharma.

Adding a Specialty Pharma Name to the Bullpen

There’s enough to like about Antares Pharma to keep an eye on it.

First Week Of June 21st Options Trading For Antares Pharma (ATRS)

First Week Of June 21st Options Trading For Antares Pharma (ATRS)

Investors in Antares Pharma Inc. saw new options begin trading this week, for the June 21st expiration.

TheStreet Quant Rating: C (Hold)